Dopamine d2 Receptor Antikörper (3rd Cytoplasmic Domain)
-
- Target Alle Dopamine d2 Receptor (DRD2) Antikörper anzeigen
- Dopamine d2 Receptor (DRD2) (Dopamine Receptor D2 (DRD2))
-
Bindungsspezifität
- 3rd Cytoplasmic Domain
-
Reaktivität
- Human, Affe
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Dopamine d2 Receptor Antikörper ist unkonjugiert
-
Applikation
- Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Spezifität
- Reacts with human DRD2
- Kreuzreaktivität (Details)
- BLAST analysis of the peptide immunogen showed no homology with other human proteins, except ZNF57 (42 % ).
- Aufreinigung
- Antigen affinity purified
- Immunogen
- Synthetic 19 amino acid peptide from 3rd cytoplasmic domain of human DRD2. Percent identity with other species by BLAST analysis: Human, Chimpanzee, Gorilla, Marmoset (100%), Gibbon, Monkey, Rabbit (95%), Dog, Bovine, Panda, Horse, Pig (89%), Mouse, Rat, Ferret, Bat, Hamster, Elephant (84%)
- Isotyp
- IgG
- Top Product
- Discover our top product DRD2 Primärantikörper
-
anti-Dopamine Receptor D2 (DRD2) (AA 194-421) antibody
DRD2 Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Dopamine Receptor D2 (DRD2) (AA 201-300) antibodyDRD2 Reaktivität: Human, Ratte, Maus WB, ELISA, IF (cc), IF (p), IHC (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Dopamine Receptor D2 (DRD2) (AA 1-110) antibodyDRD2 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 1B11 unconjugated
anti-Dopamine Receptor D2 (DRD2) (Cytoplasmic Domain) antibodyDRD2 Reaktivität: Human, Hund, Rind (Kuh), Pferd, Kaninchen, Fledermaus IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Dopamine Receptor D2 (DRD2) (AA 307-336), (C-Term) antibodyDRD2 Reaktivität: Human, Maus WB Wirt: Kaninchen Polyclonal unconjugated
anti-Dopamine Receptor D2 (DRD2) antibodyDRD2 Reaktivität: Hund WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Dopamine Receptor D2 (DRD2) (AA 301-400) antibodyDRD2 Reaktivität: Human, Ratte, Maus WB, ELISA, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Dopamine Receptor D2 (DRD2) (AA 201-300) antibody (Alexa Fluor 488)DRD2 Reaktivität: Human, Ratte, Maus WB, IF (cc), IF (p) Wirt: Kaninchen Polyclonal Alexa Fluor 488
anti-Dopamine Receptor D2 (DRD2) (AA 214-373) antibodyDRD2 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Dopamine Receptor D2 (DRD2) (Cytoplasmic Domain) antibodyDRD2 Reaktivität: Human, Hund, Rind (Kuh), Pferd, Kaninchen, Schimpanse, Gorilla IHC (p) Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
Working dilution: IHC - P (3 μg/mL - 4
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- PBS, Sodium azide 0.1 %
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C/-80 °C
- Informationen zur Lagerung
- Long term: -70°C, Short term: +4°C
-
- Target
- Dopamine d2 Receptor (DRD2) (Dopamine Receptor D2 (DRD2))
- Andere Bezeichnung
- Dopamine D2 Receptor (DRD2 Produkte)
- Synonyme
- D2DR antikoerper, D2R antikoerper, drd2b antikoerper, d2r2 antikoerper, Drd-2 antikoerper, d2dr antikoerper, d2r antikoerper, drd2 antikoerper, drd2-B antikoerper, DRD2 antikoerper, D2 antikoerper, CG18741 antikoerper, CG7569 antikoerper, DAMB antikoerper, DDR2 antikoerper, DOPR2 antikoerper, DOPR99B antikoerper, Dar2 antikoerper, Dmel\\CG18741 antikoerper, DopD1 antikoerper, DopR99B antikoerper, DopRII antikoerper, dopamine receptor D2 antikoerper, dopamine receptor D2 like antikoerper, dopamine receptor D2 L homeolog antikoerper, dopamine receptor D2 S homeolog antikoerper, Dopamine 1-like receptor 2 antikoerper, DRD2 antikoerper, drd2l antikoerper, drd2 antikoerper, Drd2 antikoerper, drd2.L antikoerper, drd2.S antikoerper, Dop1R2 antikoerper
- Pathways
- Positive Regulation of Peptide Hormone Secretion, Negative Regulation of Hormone Secretion, cAMP Metabolic Process, Inositol Metabolic Process, Regulation of G-Protein Coupled Receptor Protein Signaling, Feeding Behaviour, Negative Regulation of Transporter Activity, Regulation of long-term Neuronal Synaptic Plasticity
-
